Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Axon guidance 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
2 Axon guidance 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
3 Axon guidance 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
4 Axon guidance 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
5 Axon guidance 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
6 Axon guidance 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
7 Axon guidance 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
8 Axon guidance 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
9 Cell cycle 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
10 Cell cycle 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
11 Cell cycle 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
12 Cell cycle 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
13 Cell cycle 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
14 Cell cycle 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
15 Cell cycle 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
16 Cell cycle 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
17 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
18 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
19 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
20 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
21 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
22 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
23 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
24 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
25 Chronic myeloid leukemia 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
26 Chronic myeloid leukemia 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
27 Chronic myeloid leukemia 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
28 Chronic myeloid leukemia 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
29 Chronic myeloid leukemia 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
30 Chronic myeloid leukemia 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
31 Chronic myeloid leukemia 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
32 Chronic myeloid leukemia 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
33 ErbB signaling pathway 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
34 ErbB signaling pathway 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
35 ErbB signaling pathway 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
36 ErbB signaling pathway 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
37 ErbB signaling pathway 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
38 ErbB signaling pathway 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
39 ErbB signaling pathway 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
40 ErbB signaling pathway 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
41 MicroRNAs in cancer 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
42 MicroRNAs in cancer 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
43 MicroRNAs in cancer 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
44 MicroRNAs in cancer 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
45 MicroRNAs in cancer 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
46 MicroRNAs in cancer 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
47 MicroRNAs in cancer 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
48 MicroRNAs in cancer 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
49 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
50 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
51 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
52 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
53 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
54 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
55 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
56 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
57 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
58 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
59 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
60 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
61 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
62 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
63 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
64 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
65 Pathways in cancer 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
66 Pathways in cancer 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
67 Pathways in cancer 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
68 Pathways in cancer 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
69 Pathways in cancer 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
70 Pathways in cancer 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
71 Pathways in cancer 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
72 Pathways in cancer 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
73 Ras signaling pathway 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
74 Ras signaling pathway 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
75 Ras signaling pathway 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
76 Ras signaling pathway 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
77 Ras signaling pathway 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
78 Ras signaling pathway 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
79 Ras signaling pathway 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
80 Ras signaling pathway 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬
81 Viral myocarditis 💬
1件: ABL1 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬
82 Viral myocarditis 💬
1件: ABL1 💬 Bosutinib hydrate 💬 Bosutinib 2件:  2 , 67 💬
83 Viral myocarditis 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
84 Viral myocarditis 💬
1件: ABL1 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
85 Viral myocarditis 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
86 Viral myocarditis 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
87 Viral myocarditis 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
88 Viral myocarditis 💬
1件: ABL1 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬